Capital Increase in Genmab as a Result of Employee Warrant Exercise
May 15, 2018 12:49 ET
|
Genmab A/S
Company Announcement Copenhagen, Denmark; May 15, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 155,576 shares as a consequence of the exercise of...
Interim Report First Quarter 2018
May 08, 2018 11:04 ET
|
Genmab A/S
May 8, 2018; Copenhagen, Denmark; Interim Report for the First Quarter of 2018 Highlights USD 432 million in net sales of DARZALEX® (daratumumab); resulting in royalty income of DKK...
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma
May 07, 2018 18:36 ET
|
Genmab A/S
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple...
Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting
April 25, 2018 11:59 ET
|
Genmab A/S
Media Release 11 industry sponsored abstracts regarding Genmab programs scheduled for presentation at ASCO Annual MeetingOne oral presentation, three poster discussion sessions and seven...
Genmab A/S has published its Articles of Association
April 19, 2018 09:30 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated April 10, 2018. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel...
Selskabsvedtægter for Genmab A/S
April 19, 2018 09:30 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 10. april 2018 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018
April 17, 2018 06:48 ET
|
Genmab A/S
Company Announcement Net sales of DARZALEX in the first quarter of 2018 totaled USD 432 millionGenmab will receive royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen,...
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
April 10, 2018 13:47 ET
|
Genmab A/S
Company Announcement Copenhagen, Denmark; April 10, 2018 – Following Genmab A/S’ (Nasdaq Copenhagen: GEN) Annual General Meeting held on April 10, 2018, the Company’s Board of Directors...
Passing of Genmab A/S’ Annual General Meeting
April 10, 2018 09:43 ET
|
Genmab A/S
Company Announcement At Genmab A/S’ Annual General Meeting held today April 10, 2018 the Annual Report for 2017 was approvedDischarge was given to the Board of Directors and the Executive...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
April 03, 2018 12:28 ET
|
Genmab A/S
Company Announcement Copenhagen, Denmark; April 3, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 30,149 shares as a consequence of the exercise of...